Long, Stephanie
Ross, Cheryl
Koops, Joan
Coulthard, Katherine
Nelson, Jane
Shapkota, Archana Khadka
Hewett, Leiana
Tate-Baker, Jaclyn
Graham, Jessica
Mukula, Rose
Tetteh, Cynthia
Hoppo, Libby
Cherian, Sajiv
Pawar, Basant
Chmielewski, Heidi Lee
Gold, Lorna Murakami
Rathnayake, Geetha
Heron, Bianca
Brewster-O’Brien, Teana
Karepalli, Vijay
Maple-Brown, Louise
Batey, Robert
Morris, Peter
Davies, Jane
Fernandes, David Kiran
Thomas, Sajan
Abeyaratne, Asanga
Lawton, Paul D.
Barzi, Federica
Taylor, Sean
Mayo, Mark
Cass, Alan
Majoni, Sandawana William
Funding for this research was provided by:
National Health and Medical Research Council
Article History
Received: 26 February 2024
Accepted: 8 July 2024
First Online: 15 July 2024
Declarations
:
: All patients in the INFERR trial provided informed consent and the study is performed in accordance with the Declaration of Helsinki. The INFERR clinical trial has full ethics approval by the NT Health and Menzies School of Health Research Human Research Ethics Committee (HREC Reference Number: 2019-3536 and Central Australia Human Research Committee (CAHREC Reference Number: CA-19-3567). The trial also has full NT health Research Governance office approval (RGO NT Health SSA: EFILE2020/1471). This trial is registered with The Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12620000705987. Registered 29 June 2020.
: Not applicable.
: The authors declare no competing interests.